Every finding on record at Caring Hands Hospice LLC

It is required that the documented comprehensive assessment includes a drug profile that contains the patient's current prescription and over the counter (OTC) drugs, supplements, herbal remedies, and other alternative treatments that could affect drug therapy. The medication review process includes the identification of the following, the effectiveness of drug therapy, drug side effects, actual or potential drug interactions, duplicate drug therapy, drug therapy associated with laboratory monitoring. The assessment includes evidence that common side effects of medication in the hospice populations are anticipated, and as appropriate, preventive measurements are implemented to manage the side effects. The drug profile is updated per the hospice policy and procedure, but, at minimum, at the time of each comprehensive assessment and when new medication is added, or changes are made to existing medication. This standard was not met as evidenced by clinical record review, observation, and interview. In 1 of 5 (20%) clinical records reviewed, the hospice did not ensure medications were reviewed as part of the comprehensive assessment and updated to the drug profile. Clinical Record 3/Home Visit 2: The patient elected the hospice benefit on 03/15/2024 and resided at home. During the home visit observation with the Chaplain [Personnel Record 8], a review of medications was completed by comparing the hospice medication profile to the patient’s current medication regimen. The patient presented the current medications, which included a prescription bottle for Morphine Sulfate 30mg IR, take one tablet by mouth every 12 hours for moderate to severe pain, dated 04/18/2024. Review of the hospice medication profile revealed it did not include Morphine Sulfate. During a joint record review and interview on 05/09/2024, the Director of Professional Services agreed there was no documented evidence that Morphine was updated to the medication profile. The Administrator, who was present for the home visit, was interviewed on 05/09/2024 and agreed with the finding.